ACCURAY INCORPORATED Recognition of Deferred Revenue
ACCURAY INCORPORATED (ARAY) reported Recognition of Deferred Revenue of -$95.83 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Income Statement › Other Income
us-gaap:RecognitionOfDeferredRevenue · last filed 2018-11-06
- ACCURAY INCORPORATED recognition of deferred revenue for the quarter ending 2018-09-30 was -$95.83M.
| Period end | Recognition of Deferred Revenue 3 month |
|---|---|
| 2018-09-30 | -$95.83M 10-Q · filed 2018-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |